RADx Expands Covid-19 Home and POC Testing, Wastewater Surveillance
NIH announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel covid-19 testing technologies.
Read More
Search Results for: point-of-care testing
Qorvo Awarded $24.4M NIH Contract to Scale POC Covid-19 Antigen Testing
The NIH contract through RADx helps advance the production and market launch of the Qorvo Omnia diagnostic test platform.
Read More
Qorvo Gets FDA EUA for Omnia Rapid Covid-19 Antigen Testing
The Qorvo Omnia SARS-CoV-2 Antigen Test is authorized for the qualitative detection of nucleocapsid viral antigens from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of covid-19.
Read More
Hologic to Acquire Molecular Diagnostic Company Mobidiag
Hologic has signed a definitive agreement to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million.
Read More
BioReference Laboratories Providing Covid-19 Testing for Major League Baseball
Under the agreement with MLB, BioReference will provide on-site rapid PCR point-of-care covid-19 testing to all 30 MLB teams, leveraging Mesa Biotech’s Accula System.
Read More